SC 13D

Company

Fulgent Genetics, Inc.

Filed

October 11, 2016

Accession Number

0001193125-16-734653

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →